数字医疗健康服务平台「健康160」，通过港交所IPO聆讯，或很快香港上市

Core Viewpoint - Health 160 International Limited is preparing for an IPO on the Hong Kong Stock Exchange, having submitted its prospectus after hearing, with plans to issue up to 61.45 million shares [1][2]. Company Overview - Health 160 is a leading Chinese pharmaceutical and health products wholesaler and a digital healthcare service provider, offering a wide range of health products and comprehensive digital healthcare solutions [3]. - The company operates the largest digital healthcare service platform in China, based on the number of registered users and partnered hospitals by the end of 2024 [3]. Business Model - Health 160 provides health products through a wholesale model to corporate clients and a retail model to individual users [3]. - The digital healthcare solutions are delivered via the Health 160 platform, connecting various stakeholders in the healthcare industry, including enterprises, healthcare institutions, healthcare professionals, and individual users [3]. Market Reach - As of March 31, 2025, Health 160 has expanded its services to over 260 cities in China and established 11 regional operation centers in key areas such as Shenzhen, Beijing, Shanghai, and Guangzhou [4]. - The platform connects over 44,600 healthcare institutions, including more than 14,400 hospitals and 30,200 grassroots healthcare institutions [4]. Partnerships and User Base - The company collaborates with over 6800 private healthcare institutions primarily providing consumer medical services [5]. - Health 160 has established partnerships with over 902,300 healthcare professionals and has a registered user base of 55.2 million, with an average of 3.3 million monthly active users in 2024 [6]. Shareholder Structure - The major shareholder, Mr. Luo Ningzheng, holds 33.99% of the shares through Luo Holdings Limited, with additional voting rights from Ming Holdings Limited [7][8]. Financial Performance - Health 160's revenue for the years 2022, 2023, 2024, and the first three months of 2025 were RMB 526 million, RMB 629 million, RMB 621 million, and RMB 100 million, respectively, with corresponding net losses of RMB 120 million, RMB 106 million, RMB 108 million, and RMB 17 million [11][12].